News

For a fourth year in a row, and fifth time overall, McLaren Northern Michigan was named one of the nation’s 50 Top Cardiovascular Hospitals by IBM Watson Health™. Hospitals named as a 50 Top Cardiovascular Hospital perform better in numerous clinical, operational, and financial benchmarks compared to similar hospitals. This achievement means McLaren Northern Michigan patients spend less on procedures, have shorter stays at the hospital, experience less complications, and the community has advanced leadin...

McLaren Greater Lansing has been designated by the Blue Cross Blue Shield Association (BCBS) as a Blue Distinction Center+ for Maternity Care. Blue Distinction Centers for Specialty Care® is a directory created to identify facilities with proven expertise in delivering specialty care. The Distinction Center Program was developed with input from the medical community and evaluates hospitals’ specialty care and their ability to deliver high-quality outcomes.

McLaren St. Luke’s has received certification from DNV GL Healthcare as a Primary Plus Stroke Center, affirming the hospital’s readiness to handle a full range of stroke-related medical problems. The Primary Plus Stroke Center certification program is designed to evaluate the coordination of stroke care and guide clinical outcomes. Types of patients who might seek care from a Primary Plus Stroke Center include patients with ischemic strokes, large vessel occlusions, hemorrhagic strokes or strokes from u...

Susan Eggly, Ph.D., professor and a member of the Population Studies and Disparities Research Program at the Barbara Ann Karmanos Cancer Institute and Wayne State University (WSU) School of Medicine has been selected as winner of the Anthony and Joyce Danielski Kales Endowed Faculty Award for Innovative Cancer Researcher for her research into communication between black cancer patients and their medical oncologists. Dr. Eggly said she is very honored to receive the award, which she said was unexpected. ...

Several physicians from the Barbara Ann Karmanos Cancer Institute have been named to HOUR Detroit's 2020 Top Doctors list, which appears in the October 2020 edition of Hour Detroit Magazine. Each year, the publication conducts an online peer-to-peer review survey to determine the top physicians in southeastern Michigan. The publication requires hospitals only to list active "primary" physicians, even though others have privileges. Physicians are nominated and voted on by their peers. The M.D.'s or D.O.'...

The Barbara Ann Karmanos Cancer Institute is pleased to announce that its National Cancer Institute (NCI) Core Grant has been renewed. This renewal extends Karmanos’ prestigious NCI designation through 2025. Karmanos is among 51 centers nationwide to receive this designation. NCI-designated cancer centers are characterized by scientific excellence and the capability to integrate a diversity of research approaches to focus on the problem of cancer. They play a vital role in advancing towards the goal of ...

McLaren Greater Lansing receives Get With The Guidelines-Stroke Silver Plus Quality Achievement Award. McLaren Greater Lansing has received the American Heart Association/American Stroke Association’s Get With The Guidelines®-Stroke Silver Plus Quality Achievement Award. The award recognizes the hospital’s commitment to ensuring stroke patients receive the most appropriate treatment according to nationally recognized, research-based guidelines based on the latest scientific evidence. McLaren Greater Lan...

Researchers at the Barbara Ann Karmanos Cancer Institute have secured a one-year, $630,000 grant from the National Cancer Institute (NCI) that will help support the Institute’s clinical trials targeting underserved populations in Detroit and in the rural areas that Karmanos serves. CATCH-UP is short for the NCI P30 Cancer Center Support Grants to Create Access to Targeted Cancer Therapy for Underserved Populations. The grant supplements Karmanos’ P30 grant, a cancer center core grant that supports the e...

Karmanos Specialty Pharmacy (KSP) is pleased to announce that it has received full accreditation from the Utilization Review Accreditation Commission (URAC). This accreditation is valid for three years. The achievement serves as a key differentiator and independent validation of quality. With this designation, KSP is able to continue with its provision of specialty oral oncolytic agents. Additionally, it allows for the provision of agents in other specialized areas, such as HIV, gastroenterology, neurol...